评价新开发的热稳定成纤维细胞生长因子2修饰真皮替代物的黏弹性参数与基于照片的评估
研究制备含热稳定成纤维细胞生长因子2(FGF2-STAB®)的胶原/壳聚糖支架真皮替代物,在雌性猪人工皮肤缺损模型测试。FGF2-STAB®浓度为1.0 µg·cm-2时瘢痕弹性最佳,但1、3、6个月视觉评估各组无显著差异。
要点
- 含FGF2-STAB®的基质在皮肤黏弹性测量上优于不含FGF2的支架。
- 1、3、6个月随访视觉评估各组间无显著差异。
- 添加1.0 µg·cm-2 FGF2-STAB®的支架形成弹性最佳的瘢痕。
核心结论
- 添加1.0 µg·cm-2 FGF2-STAB®的支架形成弹性最佳的瘢痕,但对较长随访期的视觉外观无显著影响。
- 本研究为所开发产品的进一步转化研究及进入临床研究阶段奠定基础。
研究设计与样本
- 制备基于胶原/壳聚糖支架或带纳米纤维层的胶原/壳聚糖支架的真皮替代物,并分别添加0、0.1、1.0、10.0 µg·cm-2的FGF2-STAB®。
- 在雌性猪人工皮肤缺损模型中进行体内测试,于3和6个月时用皮肤黏弹性测量仪评估,并在1、3、6个月随访时基于瘢痕照片用Yeong量表与视觉模拟量表评估视觉外观。
主要发现
- 真皮替代物完全整合入所有缺损,所有创面均成功愈合。
- 含FGF2-STAB®的基质在皮肤黏弹性测量上比不含FGF2的支架取得更好结果。
- 1、3、6个月随访的视觉评估未检测到各组间显著差异。
- FGF2-STAB®改善瘢痕组织弹性的效果在猪模型中得到证实,该效果在带纳米纤维和不带纳米纤维的支架中均独立观察到。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of dermal substitutes is to mimic the basic properties of the extracellular matrix of human skin. The application of dermal substitutes to the defect reduces the formation of hypertrophic scars and improves the scar quality. This study aims to develop an original dermal substitute enriched with stable fibroblast growth factor 2 (FGF2-STAB®) and test it in an animal model. METHODS: Dermal substitutes based on collagen/chitosan scaffolds or collagen/chitosan scaffolds with nanofibrous layer were prepared and enriched with FGF2-STAB® at concentrations of 0, 0.1, 1.0, and 10.0 µg ‧ cm-2. The performance of these dermal substitutes was tested in vivo on artificially formed skin defects in female swine. The outcomes were evaluated using cutometry at 3 and 6 months. In addition, visual appearance was assessed based on photos of the scars at 1-month, 3-month and 6-month follow-ups using Yeong scale and Visual Analog Scale. RESULTS: The dermal substitute was fully integrated into all defects and all wounds healed successfully. FGF2-STAB®-enriched matrices yielded better results in cutometry compared to scaffolds without FGF2. Visual evaluation at 1, 3, and 6 months follow-ups detected no significant differences among groups. The FGF2-STAB® effectiveness in improving the elasticity of scar tissues was confirmed in the swine model. This effect was independently observed in the scaffolds with nanofibres as well as in the scaffolds without nanofibres. CONCLUSION: The formation of scars with the best elasticity was exhibited by addition 1.0 µg ‧ cm-2of FGF2-STAB® into the scaffolds, although it had no significant effect on visual appearance at longer follow-ups. This study creates the basis for further translational studies of the developed product and its progression into the clinical phase of the research.
引用
- Knoz M, Holoubek J, Lipový B, et al. Evaluation of viscoelastic parameters and photo-based assessment of newly developed dermal substitutes modified with thermostabilized fibroblast growth factor 2. Burns. 2024. PMID: 38641499. doi:10.1016/j.burns.2024.03.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。